DENTONE, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 9.528
AS - Asia 1.458
NA - Nord America 1.272
SA - Sud America 130
AF - Africa 30
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.421
Nazione #
IT - Italia 9.288
US - Stati Uniti d'America 1.186
SG - Singapore 557
CN - Cina 314
VN - Vietnam 271
BD - Bangladesh 164
BR - Brasile 81
FR - Francia 74
FI - Finlandia 45
HK - Hong Kong 42
CA - Canada 34
DE - Germania 31
MX - Messico 20
AR - Argentina 19
GB - Regno Unito 18
JP - Giappone 15
NL - Olanda 15
IN - India 13
IQ - Iraq 12
ID - Indonesia 10
PK - Pakistan 10
ZA - Sudafrica 10
PH - Filippine 8
CO - Colombia 7
EC - Ecuador 7
ES - Italia 7
JM - Giamaica 7
UA - Ucraina 7
CH - Svizzera 6
RU - Federazione Russa 6
TH - Thailandia 6
TR - Turchia 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
HN - Honduras 5
PT - Portogallo 5
VE - Venezuela 5
CR - Costa Rica 4
DZ - Algeria 4
NP - Nepal 4
PY - Paraguay 4
SE - Svezia 4
DO - Repubblica Dominicana 3
EG - Egitto 3
ET - Etiopia 3
GR - Grecia 3
KE - Kenya 3
KR - Corea 3
SV - El Salvador 3
TN - Tunisia 3
AG - Antigua e Barbuda 2
AT - Austria 2
AU - Australia 2
AZ - Azerbaigian 2
BE - Belgio 2
HR - Croazia 2
HU - Ungheria 2
IE - Irlanda 2
IR - Iran 2
JO - Giordania 2
MY - Malesia 2
RS - Serbia 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UZ - Uzbekistan 2
BB - Barbados 1
CZ - Repubblica Ceca 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
KG - Kirghizistan 1
KY - Cayman, isole 1
LC - Santa Lucia 1
LT - Lituania 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
NG - Nigeria 1
PA - Panama 1
PE - Perù 1
PL - Polonia 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.421
Città #
Genoa 4.009
Genova 3.095
Rapallo 1.049
Vado Ligure 878
San Jose 291
Singapore 283
Ashburn 105
Ho Chi Minh City 84
Council Bluffs 75
Hanoi 70
Beijing 67
Lauterbourg 64
New York 49
Helsinki 45
Hong Kong 42
Bordighera 39
Los Angeles 26
Frankfurt am Main 24
Rome 23
Santa Clara 22
Buffalo 20
Milan 20
Chicago 16
São Paulo 14
Tokyo 12
Boardman 11
Houston 11
Phoenix 11
Dallas 10
Haiphong 9
Mexico City 9
Toronto 9
Atlanta 8
Da Nang 8
Tianjin 8
Bari 7
Biên Hòa 7
City of London 7
Kyiv 7
Miami 7
Rio de Janeiro 7
Johannesburg 6
Paris 6
Zurich 6
Florence 5
Hải Dương 5
Kingston 5
Lahore 5
Las Vegas 5
London 5
Naples 5
Piscataway 5
Queens 5
San Francisco 5
Amsterdam 4
Bangkok 4
Birmingham 4
Bắc Giang 4
Charlotte 4
Denver 4
Fort Wayne 4
Kansas City 4
Madrid 4
Montreal 4
Newark 4
Orem 4
Stockholm 4
The Bronx 4
Turin 4
Washington 4
Baghdad 3
Boston 3
Brooklyn 3
Bắc Ninh 3
Cairo 3
Jakarta 3
Lamezia Terme 3
Louisville 3
Manchester 3
Mosul 3
New Orleans 3
Nha Trang 3
Nuremberg 3
Peoria 3
Quito 3
San Salvador 3
Santiago 3
Shanghai 3
Tegucigalpa 3
Abu Dhabi 2
Acalanes Ridge 2
Addis Ababa 2
Alexandria 2
Alpharetta 2
Amman 2
Ancona 2
Ankara 2
Asunción 2
Athens 2
Aurora 2
Totale 10.769
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 344
The Ligurian Human Immunodeficiency Virus Clinical Network: A Web Tool to Manage Patients With Human Immunodeficiency Virus in Primary Care and Multicenter Clinical Trials 249
Effectiveness, safety, durability and immune recovery in a retrospective, multicentre, observational cohort of ART-experienced, HIV-1-infected patients receiving maraviroc 246
Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: A multicenter regional simulation 229
A Standard Interface for Data Reuse in Infectious Diseases 223
A Web based tool for antimicrobial resistance evaluation in immunocompromised patient 216
Budget Impact Analysis of Sofosbuvir-Based Regimens for The Treatment of Hiv/Hcv Co-Infected Patients In Northern Italy: The Liguria Region Simulation 211
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors 208
Use of colistin in adult patients: a cross-sectional study 202
A comparison of inpatient admissions in 2012 from two European countries 201
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact 198
Use of maraviroc in clinical practice: a multicenter observational study 198
Cost per care of the first year of direct antiviral agents in the liguria region: A multicenter analysis 196
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 196
Ricoveri ospedalieri dei pazienti con infezione da HIV in Liguria: risultati preliminari dello studio ACTEA 193
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 193
Multicentre Clinical Trials’ data management: A hybrid solution to exploit the strengths of Electronic Data Capture and Electronic Health Records systems 191
Inpatient admissions of patients living with HIV in two European centres (UK and Italy); comparisons and contrasts 188
Rete Ligure dell’HIV: due anni di esperienza nella gestione del dato clinico 187
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 182
Bloodstream infections in critically ill patients with COVID-19 180
Control of the HIV-1 DNA reservoir is associated in vivo and in vitro with NKp46/NKp30 (CD335 CD337) inducibility and interferon gamma production by transcriptionally unique NK cells 177
Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA < 50 cp/mL 172
Weight gain: A possible side effect of all antiretrovirals 166
On-field evaluation of a ultra-rapid fluorescence immunoassay as a frontline test for SARS-CoV-2 diagnostic 165
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 159
From Liguria HIV Web to Liguria Infectious Diseases Network: How a Digital Platform Improved Doctors' Work and Patients' Care 153
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 153
Web interaction to improve collaboration in monitoring of microbial infections 151
Assessment of appropriateness of first-line combined antiretroviral treatment (cART): the preliminary results of Liguria experience V.E.L.A. study 148
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 148
LiHlm-Web: a web-application in order to collect, share and analyze immunological data of HIV patients in multicentric studies 146
CD8+CD28-CD127loCD39+ T reg: a new biomarker for HIV infection 143
CD8+CD28-CD127loCD39+Treg Expansion: a New Pathogenic Mechanism for HIV Infection? 143
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports 142
Aspergillus-PCR in bronchoalveolar lavage - diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients 141
The impact of liver disease: a leading cause of hospital admissions in people living vith HIV 137
Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients 136
Reactivation of Herpes Simplex Virus Type 1 (HSV-1) Detected on Bronchoalveolar Lavage Fluid (BALF) Samples in Critically Ill COVID-19 Patients Undergoing Invasive Mechanical Ventilation: Preliminary Results from Two Italian Centers 136
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports 135
Early effects of ventilatory rescue therapies on systemic and cerebral oxygenation in mechanically ventilated COVID-19 patients with acute respiratory distress syndrome: a prospective observational study 134
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 133
Distinct features of immune activation and exhaustion markers in people with perinatally-acquired HIV 132
A very rare case of mycobacterium gordonae infection of the breast 131
Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting? 126
Valutazione di parametri di immunità innata e di infiammazione correlati ad aspetti clinico-metabolici in una coorte di pazienti HIV positivi con carica virale non rilevabile 125
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 125
Lung distribution of gas and blood volume in critically ill COVID-19 patients: a quantitative dual-energy computed tomography study 125
Enterococcal bloodstream infections in critically ill patients with COVID-19: a case series 124
Characterization of T lymphocytes in severe COVID-19 patients 123
Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals 120
A comparative analysis of the first and second COVID-19 wave in Italy: evaluation of mortality in the Infectious Disease Unit of Genoa University Hospital 119
Use of ceftaroline in hospitalized patients with and without covid-19: A descriptive cross-sectional study 119
Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoring 117
High-temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccines 116
Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance 116
Effect of SARS-CoV-2 vaccination in a vulnerable COVID-19 cohort: a real-life experience in an Italian Hospital 114
The Ligurian HIV network: How medical informatics standards can help clinical research 114
Early administration of bamlanivimab in combination with etesevimab increases the benefits of covid-19 treatment: Real-world experience from the liguria region 114
Utilizzo di Maraviroc nella pratica clinica: studio multicentrico osservazionale (MARHIV STUDY) 112
HCMV-controlling NKG2C+ NK cells originate from novel circulating inflammatory precursors 110
T2Bacteria and T2Resistance Assays in Critically Ill Patients with Sepsis or Septic Shock: A Descriptive Experience 109
Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders 106
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 106
Spread of carbapenem-resistant gram-negatives and candida auris during the covid-19 pandemic in critically ill patients: One step back in antimicrobial stewardship? 105
Immunological profile of an infant treated with integrase inhibitor from the neonatal period 104
Healthcare Worker Study Cohort to Determine the Level and Durability of Cellular and Humoral Immune Responses after Two Doses of SARS-CoV-2 Vaccination 101
Higher mortality and intensive care unit admissions in COVID-19 patients with liver enzyme elevations 101
1942. Effect of {SARS}-{CoV}-2 Vaccination in a Frailty {COVID}-19 Cohort: a Real Life Experience in a Northern Italy Hospital 100
Clinical efficacy of eucaloric ketogenic nutrition in the COVID-19 cytokine storm: A retrospective analysis of mortality and intensive care unit admission 100
Una rete multicentrica standardizzata per gestire e analizzare le co-morbidità e gli effetti collaterali legati a terapie HAART in pazienti con infezione da HIV 99
Lipid profile improvement in virologically suppressed hiv-1-infected patients switched to dolutegravir/ abacavir/lamivudine: Data from the SCOLTA project 99
The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient-A Case Study 99
Inflammatory effects of atazanavir/ritonavir versus darunavir/ritonavir in treatment naïve, HIV-1-infected patients 98
Early Clinical Experience with Molnupiravir for Mild to Moderate Breakthrough COVID-19 among Fully Vaccinated Patients at Risk for Disease Progression 97
Neutralizing monoclonal antibodies for the prevention of severe COVID-19: a retrospective study during Omicron BA.1 variant surge 95
Triple combination therapy with two antivirals and monoclonal antibodies for persistent or relapsed SARS-CoV-2 infection in immunocompromised patients 95
Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19 95
High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection 94
Ten Years of Medical Informatics and Standards Support for Clinical Research in an Infectious Diseases Network 92
Clinical presentation of secondary infectious complications in COVID-19 patients in intensive care unit treated with tocilizumab or standard of care 90
Behind the screens: Clinical decision support methodologies - A review 89
Clinical significance of inflammatory markers of bacterial infection in critically ill patients with COVID-19 after treatment with anti-inflammatory and immunomodulatory drugs: A complex new scenario 88
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study 87
Levels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary study 86
Prevalence of Viral Hepatitis in Unselected, Consecutively Enrolled Patients Hospitalised for SARS-CoV-2 80
High prevalence of olfactory and taste disorder during SARS-CoV-2 infection in outpatients 76
Factors Associated With Weight Gain in People Treated With Dolutegravir 70
West Nile virus: epidemiology, prevention, clinical features, diagnosis, treatment, and open research questions 66
Is a step-down antiretroviral therapy necessary to fight severe acute respiratory syndrome coronavirus 2 in HIV-infected patients? 65
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 59
Early and Polyantigenic CD4 T Cell Responses Correlate with Mild Disease in Acute COVID-19 Donors 48
Triple antiviral treatment for COVID-19 in an immunocompromised patient 20
Totale 12.650
Categoria #
all - tutte 46.644
article - articoli 40.940
book - libri 0
conference - conferenze 5.331
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 373
Totale 93.288


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022789 31 35 38 73 47 46 33 180 70 87 42 107
2022/20231.299 96 134 11 156 147 163 54 86 140 102 187 23
2023/2024832 43 82 16 106 80 171 50 53 34 33 62 102
2024/20252.491 80 146 60 189 251 227 287 501 90 125 286 249
2025/20264.485 555 171 482 317 531 222 570 222 344 428 298 345
2026/2027309 309 0 0 0 0 0 0 0 0 0 0 0
Totale 12.650